Currently out of the existing stock ratings of Joseph Stringer, 118 are a BUY (95.93%), 5 are a HOLD (4.07%).

Joseph Stringer

Work Performance Price Targets & Ratings Chart

Analyst Joseph Stringer works at NEEDHAM with a stock forecast success ratio of 24.38% fulfilled within 96.72 days on average.

Joseph Stringer’s has documented 241 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PHAT, Phathom Pharmaceuticals at 23-Feb-2024.

Wall Street Analyst Joseph Stringer

Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 12/7/2023. The price target of $45 was fulfilled within 8 days with a profit of $7 (18.42%) receiving and performance score of 23.03.

Average potential price target upside

APLS Apellis Pharmaceuticals INZY Inozyme Pharma  ACAD ACADIA Pharmaceuticals ALNY Alnylam Pharmaceuticals ANNX Annexon  ICPT Intercept Pharmaceuticals TBPH Theravance Biopharma ARNA Arena Pharmaceuticals RYTM Rhythm Pharmaceuticals VIR Vir Biotechnology STOK Stoke Therapeutics PHAT Phathom Pharmaceuticals CARA Cara Therapeutic IONS Ionis Pharmaceuticals PCVX Vaxcyte  PLRX Pliant Therapeutics  RNA Avidity Biosciences  CDTX Cidara Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

80

$12.41 (18.36%)

68

18 days ago

5/6 (83.33%)

$17.44 (27.88%)

292

Buy

79

$11.41 (16.88%)

75

25 days ago

6/10 (60%)

$13.64 (20.87%)

353

Buy

75

$7.41 (10.96%)

56

1 months ago

9/10 (90%)

$8.82 (13.33%)

242

Buy

92

$24.41 (36.11%)

82

1 months 7 days ago

3/12 (25%)

$25.7 (38.76%)

108

Buy

106

$38.41 (56.83%)

67

1 months 12 days ago

3/17 (17.65%)

$36.63 (52.80%)

382

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Joseph Stringer is most bullish on?

Potential upside of $37.19 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

Which stock is Joseph Stringer is most reserved on?

Potential downside of -$18.87 has been obtained for PCVX (VAXCYTE )

What Year was the first public recommendation made by Joseph Stringer?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?